Molecular markers for osteoarthritis: The road ahead

Current Opinion in Rheumatology

Volumn 14, Issue 5, 2002, Pages 585-589

  DeGroot, Jeroen ^a   Bank, Ruud A ^a   Tchetverikov, Ilja ^a   Verzijl, Nicole ^a   TeKoppele, Johan M ^a  

^a TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CHONDROITIN SULFATE; COLLAGEN; COLLAGEN TYPE 2; CYTOKINE; EPITOPE; HYALURONIC ACID; KERATAN SULFATE; MATRIX METALLOPROTEINASE; OSTEOCALCIN; PROTEOGLYCAN; SIALOPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RECEPTOR 2; CROSS LINKING REAGENT;

ARTHRITIS; ARTICULAR CARTILAGE; COLLAGEN SYNTHESIS; CROSS LINKING; DISEASE COURSE; HUMAN; INFLAMMATION; OSTEOARTHRITIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYNOVIUM; EXTRACELLULAR MATRIX; GENETIC MARKER; GENETICS; METABOLISM; PATHOLOGY;

COLLAGEN TYPE II; CROSS-LINKING REAGENTS; EXTRACELLULAR MATRIX; GENETIC MARKERS; HUMAN; MATRIX METALLOPROTEINASES; OSTEOARTHRITIS; PROTEOGLYCANS; SUPPORT, NON-U.S. GOV'T; HUMANS;

EID: 0036707741     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200209000-00019     Document Type: Review

References (35)

1. The increased swelling and instantaneous deformation of osteoarthritic cartilage is highly correlated with collagen degradation
2. Collagen type II C-telopeptide fragments as an index of cartilage degradation
3. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: Relations with disease activity and joint damage
4. Evidence for altered synthesis of type II collagen in patients with osteoarthritis
5. An analysis of 14 molecular markers for monitoring osteoarthritis: Segregation of the markers into clusters and distinguishing osteoarthritis at baseline
6. Prediction of osteoarthritis progression using molecular markers of cartilage metabolism
7. The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone
8. Detection of collagenase-induced damage of collagen by 9A4, a monoclonal C-terminal neoepitope antibody
9. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase
10. Analysis of collagenase-cleavage of type II collagen using a neoepitope ELISA
11. Urinary collagen crosslink excretion in STR/1 N mice indicates cartilage destruction as an early event in the development of spontaneous osteoarthritis
12. An analysis of 14 molecular markers for monitoring osteoarthritis: Relationship of the markers to clinical end-points
13. Accumulation of advanced glycation endproducts reduces chondrocyte-mediated extracellular matrix turnover in human articular cartilage
14. Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: The role of advanced glycation end products
15. Levels of keratan sulfate in the serum and synovial fluid of patients with osteoarthritis of the knee
16. Serum keratan sulfate levels in osteoarthritis patients
17. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan: Implications for pathogenesis
18. Cross-sectional comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage
19. TGF-beta1 as a prognostic factor in the process of early osteoarthrosis in the rabbit knee
20. Cartilage and bone biologic markers in the synovial fluid of osteoarthritic patients after hyaluronan injections in the knee
21. Cartilage damage after intraarticular exposure to collagenase 3
22. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis: Involvement of YKL-40 in the joint pathology
23. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis
24. Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis
25. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis
26. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: Relationship with synovitis and steroid treatment
27. Tissue inhibitor of metalloprotease-1 (TIMP-1) serum level may predict progression of hip osteoarthritis
28. The canine "groove" model, compared with the ACLT model of osteoarthritis
29. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice
30. Type II collagen degradation in articular cartilage fibrillation after anterior cruciate ligament transection in rats
31. Relationship between osteoprotegerin/osteoclastogenesis inhibitory factor concentration in syncvial fluid and disease severity in individuals with osteoarthritis of the knee
32. Serum nitrate and nitrite levels in patients with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis
33. Osteoarthritis or osteoarthrosis: The definition of inflammation becomes a semantic issue in the genomic era of molecular medicine
34. Concentration and localization of YLK-40 in hip joint diseases
35. Bone mineral density and bone turnover in patients with knee osteoarthritis compared with generalized osteoarthritis